These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20589309)

  • 1. An engineered riboswitch as a potential gene-regulatory platform for reducing antibacterial drug resistance.
    Feng X; Liu L; Duan X; Wang S
    Chem Commun (Camb); 2011 Jan; 47(1):173-5. PubMed ID: 20589309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered riboswitch as a gene-regulatory platform for reducing antibiotic resistance.
    Liu L; Wang S
    Methods Mol Biol; 2014; 1111():251-8. PubMed ID: 24549625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
    Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
    Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli.
    Papagiannitsis CC; Loli A; Tzouvelekis LS; Tzelepi E; Arlet G; Miriagou V
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2185-8. PubMed ID: 17353248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting metallo-β-lactamase enzymes in antibiotic resistance.
    King DT; Strynadka NC
    Future Med Chem; 2013 Jul; 5(11):1243-63. PubMed ID: 23859206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SHV-5 extended-spectrum beta-lactamases in clinical isolates of Escherichia coli in Malaysia.
    Subramaniam G; Palasubramaniam S; Navaratnam P
    Indian J Med Microbiol; 2006 Jul; 24(3):205-7. PubMed ID: 16912441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the genetic structure and transmission mechanism of a plasmid-mediated AmpC beta-lactamase].
    Lu WX; Wei ZQ; Yu YS; Chen YG; Li LJ
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3043-7. PubMed ID: 16324403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance in bacteria: novel metalloenzyme inhibitors.
    Kim SK; Sims CL; Wozniak SE; Drude SH; Whitson D; Shaw RW
    Chem Biol Drug Des; 2009 Oct; 74(4):343-8. PubMed ID: 19751419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
    Xiong Z; Zhu D; Zhang Y; Wang F
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of mecillinam against AmpC beta-lactamase-producing Escherichia coli.
    Brenwald NP; Andrews J; Fraise AP
    J Antimicrob Chemother; 2006 Jul; 58(1):223-4. PubMed ID: 16698846
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional metagenomics reveals diverse beta-lactamases in a remote Alaskan soil.
    Allen HK; Moe LA; Rodbumrer J; Gaarder A; Handelsman J
    ISME J; 2009 Feb; 3(2):243-51. PubMed ID: 18843302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model system to evaluate the effect of ampD mutations on AmpC-mediated beta-lactam resistance.
    Schmidtke AJ; Hanson ND
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2030-7. PubMed ID: 16723562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel IMP-1 metallo-beta-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1.
    Moloughney JG; D Thomas J; Toney JH
    FEMS Microbiol Lett; 2005 Feb; 243(1):65-71. PubMed ID: 15668002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli.
    Odeh R; Kelkar S; Hujer AM; Bonomo RA; Schreckenberger PC; Quinn JP
    Clin Infect Dis; 2002 Jul; 35(2):140-5. PubMed ID: 12087519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level cefepime resistance in Escherichia coli from Singapore producing OXA-1 beta-lactamase.
    Koh TH; Wang G; Koh TY
    Int J Antimicrob Agents; 2008 Apr; 31(4):382-3. PubMed ID: 18178066
    [No Abstract]   [Full Text] [Related]  

  • 18. NOTA: a potent metallo-β-lactamase inhibitor.
    Somboro AM; Tiwari D; Bester LA; Parboosing R; Chonco L; Kruger HG; Arvidsson PI; Govender T; Naicker T; Essack SY
    J Antimicrob Chemother; 2015 May; 70(5):1594-6. PubMed ID: 25567963
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of AmpC beta-lactamase in Enterobacter cloacae isolated from retail ground beef, cattle farm and processing facilities.
    Kim SH; Wei CI
    J Appl Microbiol; 2007 Aug; 103(2):400-8. PubMed ID: 17650200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-lactam antibiotic resistance: a current structural perspective.
    Wilke MS; Lovering AL; Strynadka NC
    Curr Opin Microbiol; 2005 Oct; 8(5):525-33. PubMed ID: 16129657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.